Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas.

Uterine myomas and endometriosis are benign hormone-dependent diseases affecting women of reproductive age. Substantial efforts have been made to develop innovative medical options for treating the...